Anti-PPP1R3A monoclonal antibody

Pre-made anti-PPP1R3A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PPP1R3A/PPP1R3A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1437-Ab-1/ GM-Tg-hg-IP1437-Ab-2Anti-Human PPP1R3A monoclonal antibodyHuman
GM-Tg-rg-IP1437-Ab-1/ GM-Tg-rg-IP1437-Ab-2Anti-Rat PPP1R3A monoclonal antibodyRat
GM-Tg-mg-IP1437-Ab-1/ GM-Tg-mg-IP1437-Ab-2Anti-Mouse PPP1R3A monoclonal antibodyMouse
GM-Tg-cynog-IP1437-Ab-1/ GM-Tg-cynog-IP1437-Ab-2Anti-Cynomolgus/ Rhesus macaque PPP1R3A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1437-Ab-1/ GM-Tg-felg-IP1437-Ab-2Anti-Feline PPP1R3A monoclonal antibodyFeline
GM-Tg-cang-IP1437-Ab-1/ GM-Tg-cang-IP1437-Ab-2Anti-Canine PPP1R3A monoclonal antibodyCanine
GM-Tg-bovg-IP1437-Ab-1/ GM-Tg-bovg-IP1437-Ab-2Anti-Bovine PPP1R3A monoclonal antibodyBovine
GM-Tg-equg-IP1437-Ab-1/ GM-Tg-equg-IP1437-Ab-2Anti-Equine PPP1R3A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1437-Ab-1/ GM-Tg-hg-IP1437-Ab-2; GM-Tg-rg-IP1437-Ab-1/ GM-Tg-rg-IP1437-Ab-2;
GM-Tg-mg-IP1437-Ab-1/ GM-Tg-mg-IP1437-Ab-2; GM-Tg-cynog-IP1437-Ab-1/ GM-Tg-cynog-IP1437-Ab-2;
GM-Tg-felg-IP1437-Ab-1/ GM-Tg-felg-IP1437-Ab-2; GM-Tg-cang-IP1437-Ab-1/ GM-Tg-cang-IP1437-Ab-2;
GM-Tg-bovg-IP1437-Ab-1/ GM-Tg-bovg-IP1437-Ab-2; GM-Tg-equg-IP1437-Ab-1/ GM-Tg-equg-IP1437-Ab-2
Products NameAnti-PPP1R3A monoclonal antibody
Formatmab
Target NamePPP1R3A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PPP1R3A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1437-Ag-1Recombinant multi-species PPR3A/ PPP1R3A/ GM protein


    Target information

    Target IDGM-IP1437
    Target NamePPP1R3A
    Gene ID5506,140491,500036,703562,482411,101084864,784877,100055851
    Gene Symbol and SynonymsGM,PP1G,PPP1R3,PPP1R3A,RG1,RGD1561312,RGL
    Uniprot AccessionQ16821
    Uniprot Entry NamePPR3A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000154415
    Target ClassificationTumor-associated antigen (TAA)

    The target: PPP1R3A, gene name: PPP1R3A, also named as GM, PP1G, PPP1R3. The glycogen-associated form of protein phosphatase-1 (PP1) derived from skeletal muscle is a heterodimer composed of a 37-kD catalytic subunit and a 124-kD targeting and regulatory subunit. This gene encodes the regulatory subunit which binds to muscle glycogen with high affinity, thereby enhancing dephosphorylation of glycogen-bound substrates for PP1 such as glycogen synthase and glycogen phosphorylase kinase. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.